Templates and models of monoamine transporter proteins

Current Medicinal Chemistry

Volumn 18, Issue 30, 2011, Pages 4651-4658

  Sylte, I ^a   Ravna, A W ^a   Dahl, S G ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

3 Dimensional structure; Dopamine transporter; Drug interactions; Molecular mechanisms; Molecular structure; Monoamine transporters; Noradrenaline transporter; Serotonin transporter

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; LACTOSE PERMEASE; MONOAMINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN;

AQUIFEX AEOLICUS; ARTICLE; CRYSTAL STRUCTURE; ENZYME STRUCTURE; ESCHERICHIA COLI; HUMAN; NONHUMAN; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

EID: 80053514268     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797379203     Document Type: Article

References (78)

1. Scapin, G. Structural biology and drug discovery. Curr. Pharm. Des., 2006, 12, 2087-2097. (Pubitemid 43891405)
2. Klebe, G. Virtual ligand screening: strategies, perspectives and limitations.Drug Discov. Today, 2006, 11, 580-594.
3. Hopkins, A.L.; Groom, C.R. The druggable genome. Nat. Rev. Drug Discov., 2002, 1, 727-730. (Pubitemid 37361545)
4. The Research Collaboratory for Structural Bioinformatics (RCSB). ProteinData Bank. An Information Portal to Biological Macromolecular Structures.http://www.rcsb.org/pdb/home/home.do. (Accessed February 16, 2011
5. Drews, J. Drug discovery: a historical perspective. Science, 2000, 287, 1960-1964. (Pubitemid 30158662)
6. White, S. Membrane proteins of known 3D structure.http://blanco.biomol. uci.edu/Membrane-Proteins-xtal.html. (Accessed April 1, 2011
7. Schulz, G.E. A new classification of membrane protein crystals. J. Mol.Biol., 2011, 407(5), 640-646.
8. Bowie, J.U. Solving the membrane protein folding problem. Nature, 2005, 438, 581-589. (Pubitemid 41740561)
9. Wallin, E.; von Heijne, G. Genome-wide analysis of integral membraneproteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci., 1998, 7, 1029-1038. (Pubitemid 28216544)
10. Wieman, H.; Tondel, K.; Anderssen, E.; Drablos, F. Homology- basedmodelling of targets for rational drug design. Mini Rev. Med. Chem., 2004, 4, 793-804. (Pubitemid 39149479)
11. Andersen, J.; Olsen, L.; Hansen, K.B.; Taboureau, O.; Jorgensen, F.S.;Jorgensen, A.M.; Bang-Andersen, B.; Egebjerg, J.; Stromgaard, K.;Kristensen, A.S. Mutational mapping and modeling of the binding site for(S)-citalopram in the human serotonin transporter. J. Biol. Chem., 2010, 285, 2051-2063.
12. Sinning, S.; Musgaard, M.; Jensen, M.; Severinsen, K.; Celik, L.; Koldso, H.;Meyer, T.; Bols, M.; Jensen, H.H.; Schiott, B.; Wiborg, O. Binding andorientation of tricyclic antidepressants within the central substrate site of thehuman serotonin transporter. J. Biol. Chem., 2010, 285, 8363-8374.
13. Kurczab, R.; Nowak, M; Chilmonczyk, Z.; Sylte, I.; Bojarski A.J. Thedevelopment and validation of a novel virtual screening cascade protocol toidentify potential serotonin 5-HT(7)R antagonists. Bioorg. Med. Chem. Lett., 2010. 20(8), 2465-2468.
14. Beuming, T.; Shi, L.; Javitch, J.A.; Weinstein, H. A comprehensivestructure-based alignment of prokaryotic and eukaryoticneurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structureto probe NSS structure and function. Mol. Pharmacol., 2006, 70, 1630-1642.
15. Lundstrom, K. Structural genomics of GPCRs. Trends Biotechnol., 2005, 23, 103-108. (Pubitemid 40127346)
16. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.;Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor.Science, 2000, 289, 739-745. (Pubitemid 30650186)
17. Cherezov, V.; Rosenbaum, D.M.; Hanson, M.A.; Rasmussen, S.G.; Thian, F.S.; Kobilka, T.S.; Choi, H.J.; Kuhn, P.; Weis, W.I.; Kobilka, B.K.; Stevens, R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science, 2007, 318, 1258-1265. (Pubitemid 350172884)
18. Dahl, S.G.; Sylte, I.; Ravna, A.W. Structures and models of transporterproteins. J. Pharmacol. Exp. Ther., 2004, 309, 853-860.
19. Hahn, M.K.; Blakely, R.D. Monoamine transporter gene structure andpolymorphisms in relation to psychiatric and other complex disorders.Pharmacogenomics J., 2002, 2, 217-235. (Pubitemid 35023581)
20. Rothman, R.B.; Baumann, M.H. Monoamine transporters andpsychostimulant drugs. Eur. J. Pharmacol., 2003, 479, 23-40.
21. Jayanthi, L.D.; Ramamoorthy, S. Regulation of monoamine transporters:influence of psychostimulants and therapeutic antidepressants. AAPS J, 2005, 7, E728-E738.
22. White, K.J.; Walline, C.C.; Barker, E.L. Serotonin transporters: implicationsfor antidepressant drug development. AAPS J, 2005, 7, E421-E433.
23. Talbot, P.S.; Bradley, S.; Clarke, C.P.; Babalola, K.O.; Philipp, A.W.;Brown, G.; McMahon, A.W.; Matthews, J.C. Brain serotonin transporteroccupancy by oral sibutramine dosed to steady state: a PET study using(11)C-DASB in healthy humans. Neuropsychopharmacology, 2010, 35, 741-751.
24. Ravna, A.W.; Edvardsen, O. A putative three-dimensional arrangement ofthe human serotonin transporter transmembrane helices: a tool to aidexperimental studies. J. Mol. Graph. Model., 2001, 20, 133-144. (Pubitemid 33135510)
25. Ravna, A.W.; Jaronczyk, M.; Sylte, I. A homology model of SERT based onthe LeuT(Aa) template. Bioorg. Med. Chem. Lett., 2006, 16, 5594-5597. (Pubitemid 44415450)
26. Ravna, A.W.; Sylte, I.; Dahl, S.G. Molecular model of the neural dopaminetransporter. J. Comput. Aided Mol. Des., 2003, 17, 367-382.
27. Ravna, A.W.; Sylte, I.; Dahl, S.G. Molecular mechanism of citalopram andcocaine interactions with neurotransmitter transporters. J. Pharmacol. Exp.Ther., 2003, 307, 34-41. (Pubitemid 37151889)
28. Ravna, A.W.; Sylte, I.; Kristiansen, K.; Dahl, S.G. Putative drug bindingconformations of monoamine transporters. Bioorg. Med. Chem., 2006, 14, 666-675. (Pubitemid 41767571)
29. + antiporter NhaA. Receptors Channels, 2001, 7, 319-328. (Pubitemid 32684991)
30. Edvardsen, O.; Dahl, S.G. A putative model of the dopamine transporter.Brain Res Mol. Brain Res., 1994, 27, 265-274. (Pubitemid 24379209)
31. Chen, J.G.; Liu-Chen, S.; Rudnick, G. Determination of external looptopology in the serotonin transporter by site-directed chemical labeling. J. Biol. Chem., 1998, 273, 12675-12681. (Pubitemid 28240647)
32. Reizer, J.; Reizer, A.; Saier, M.H., Jr. A functional superfamily ofsodium/solute symporters. Biochim. Biophys. Acta, 1994, 1197, 133-166.
33. Kitayama, S.; Shimada, S.; Xu, H.; Markham, L.; Donovan, D.M.; Uhl, G.R.Dopamine transporter site-directed mutations differentially alter substratetransport and cocaine binding. Proc. Natl. Acad. Sci. U S A, 1992, 89, 7782-7785.
34. Han, D.D.; Gu, H.H. Comparison of the monoamine transporters fromhuman and mouse in their sensitivities to psychostimulant drugs. BMCPharmacology, 2006. 6(6).
35. Barker, E.L.; Perlman, M.A.; Adkins, E.M.; Houlihan, W.J.; Pristupa, Z.B.;Niznik, H.B.; Blakely, R.D. High affinity recognition of serotonin transporterantagonists defined by species-scanning mutagenesis. An aromatic residue intransmembrane domain I dictates species-selective recognition of citalopramand mazindol. J. Biol. Chem., 1998, 273, 19459-19468. (Pubitemid 28366995)
36. Chen, J.G.; Rudnick, G. Permeation and gating residues in serotonintransporter. Proc. Natl. Acad. Sci. USA, 2000, 97, 1044-1049.
37. Chen, J.G.; Sachpatzidis, A.; Rudnick, G. The third transmembrane domainof the serotonin transporter contains residues associated with substrate andcocaine binding. J. Biol. Chem., 1997, 272, 28321-28327. (Pubitemid 27517776)
38. Kitayama, S.; Morita, K.; Dohi, T.; Wang, J.B.; Davis, S.C.; Uhl, G.R.Dissection of dopamine and cocaine binding sites on the rat dopaminetransporter expressed in COS cells. Ann. N. Y. Acad. Sci., 1996, 801, 388-393. (Pubitemid 27030984)
39. Mitsuhata, C.; Kitayama, S.; Morita, K.; Vandenbergh, D.; Uhl, G.R.; Dohi, T. Tyrosine-533 of rat dopamine transporter: involvement in interactionswith 1-methyl-4-phenylpyridinium and cocaine. Brain Res. Mol. Brain Res., 1998, 56, 84-88. (Pubitemid 28271664)
40. Barker, E.L.; Blakely, R.D. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions oftricyclic antidepressants with the human serotonin transporter. Mol. Pharmacol., 1996, 50, 957-965. (Pubitemid 26347717)
41. Kitayama, S.; Wang, J.B.; Uhl, G.R. Dopamine transporter mutantsselectively enhance MPP+ transport. Synapse, 1993, 15, 58-62. (Pubitemid 23262756)
42. Pantanowitz, S.; Bendahan, A.; Kanner, B.I. Only one of the charged aminoacids located in the transmembrane alpha-helices of the gamma-aminobutyricacid transporter (subtype A) is essential for its activity. J. Biol. Chem., 1993, 268, 3222-3225. (Pubitemid 23070948)
43. Sur, C.; Betz, H.; Schloss, P. A single serine residue controls the cationdependence of substrate transport by the rat serotonin transporter. Proc. Natl. Acad. Sci. USA, 1997, 94, 7639-7644. (Pubitemid 27345369)
44. Sur, C.; Schloss, P.; Betz, H. The rat serotonin transporter: identification ofcysteine residues important for substrate transport. Biochem. Biophys. Res.Commun., 1997, 241, 68-72. (Pubitemid 28033540)
45. + antiporter inEscherichia coli. J. Exp. Biol., 1994, 196, 443-456.
46. Williams, K.A. Three-dimensional structure of the ion-coupled transportprotein NhaA. Nature, 2000, 403, 112-115. (Pubitemid 30038532)
47. Abramson, J.; Smirnova, I.; Kasho, V.; Verner, G.; Kaback, H.R.; Iwata, S.Structure and mechanism of the lactose permease of Escherichia coli.Science, 2003, 301, 610-615. (Pubitemid 36927939)
48. Barker, E.L.; Moore, K.R.; Rakhshan, F.; Blakely, R.D. Transmembranedomain I contributes to the permeation pathway for serotonin and ions in theserotonin transporter. J. Neurosci., 1999, 19, 4705-4717. (Pubitemid 29270106)
49. Cardozo, T.; Totrov, M.; Abagyan, R. Homology modeling by the ICMmethod. Proteins, 1995, 23, 403-414.
50. Yamashita, A.; Singh, S.K.; Kawate, T.; Jin, Y.; Gouaux, E. Crystal structureof a bacterial homologue of Na+/Cl-dependent neurotransmittertransporters. Nature, 2005, 437, 215-223. (Pubitemid 41294479)
51. Andersen, J.; Taboureau, O.; Hansen, K.B.; Olsen, L.; Egebjerg, J.;Stromgaard, K.; Kristensen, A.S. Location of the antidepressant binding sitein the serotonin transporter: importance of Ser-438 in recognition ofcitalopram and tricyclic antidepressants. J. Biol. Chem., 2009, 284, 10276-10284.
52. Celik, L.; Sinning, S.; Severinsen, K.; Hansen, C.G.; Moller, M.S.; Bols, M.;Wiborg, O.; Schiott, B. Binding of serotonin to the human serotonintransporter. Molecular modeling and experimental validation. J. Am. Chem.Soc., 2008, 130, 3853-3865. (Pubitemid 351429851)
53. Kaufmann, K.W.; Dawson, E.S.; Henry, L.K.; Field, J.R.; Blakely, R.D.;Meiler, J. Structural determinants of species-selective substrate recognitionin human and Drosophila serotonin transporters revealed throughcomputational docking studies. Proteins, 2009, 74, 630-642.
54. Walline, C.C.; Nichols, D.E.; Carroll, F.I.; Barker, E.L. Comparativemolecular field analysis using selectivity fields reveals residues in the thirdtransmembrane helix of the serotonin transporter associated with substrateand antagonist recognition. J. Pharmacol. Exp. Ther., 2008, 325, 791-800. (Pubitemid 351724338)
55. Singh, S.K.; Yamashita, A.; Gouaux, E. Antidepressant binding site in abacterial homologue of neurotransmitter transporters. Nature, 2007, 448, 952-956. (Pubitemid 47312772)
56. Zhou, Z.; Zhen, J.; Karpowich, N.K.; Goetz, R.M.; Law, C.J.; Reith, M.E.;Wang, D.N. LeuT-desipramine structure reveals how antidepressants blockneurotransmitter reuptake. Science, 2007, 317, 1390-1393. (Pubitemid 47417479)
57. Zhou, Z.; Zhen, J.; Karpowich, N.K.; Law, C.J.; Reith, M.E.; Wang, D.N.Antidepressant specificity of serotonin transporter suggested by three LeuTSSRIstructures. Nat. Struct. Mol. Biol., 2009, 16, 652-657.
58. Adkins, E.M.; Barker, E.L.; Blakely, R.D. Interactions of tryptaminederivatives with serotonin transporter species variants implicatetransmembrane domain I in substrate recognition. Mol. Pharmacol., 2001.59(3), 514-523. (Pubitemid 32179931)
59. Henry, L.K.; Field, J.R.; Adkins, M.L.; Parnas, M.L.; Vaughan, R.A.; Zou, M.F.; Newman, A.H.; Blakely, R.D. Tyr-95 and Ile-172 in transmembranesegments 1 and 3 of human serotonin transporters interact to establish highaffinity recognition of antidepressants. J. Biol. Chem., 2006. 281, 2012-2023. (Pubitemid 43845789)
60. Shi, L.; Quick, M.; Zhao, Y.; Weinstein, H.; Javitch, J.A. The mechanism ofa neurotransmitter:sodium symporter-inward release of Na+ and substrate istriggered by substrate in a second binding site. Mol. Cell, 2008. 30, 667-677. (Pubitemid 351815131)
61. Singh, S.K.; Piscitelli, C.L.; Yamashita, A.; Gouaux, E. A competitiveinhibitor traps LeuT in an open-to-out conformation. Science, 2008, 322, 1655-16561.
62. Abramson, J.; E.M. Wright, Structure and function of Na(+)-symporters withinverted repeats. Curr. Opin. Struct. Biol., 2009. 19, 425-432.
63. Faham, S.; Watanabe A.; Besserer G.M., Cascio, D.; Specht, A.; Hirayama, B.A.; Wright, E.M.; Abramson, J. The crystal structure of a sodium galactosetransporter reveals mechanistic insights into Na+/sugar symport. Science, 2008. 321, 810-814.
64. Shaikh, S.A.; Tajkhorshid E. Modeling and dynamics of the inward-facingstate of a Na+/Cl- dependent neurotransmitter transporter homologue. PLoSComp. Biol., 2010. 6(8).
65. Ravna, A.W.; Sylte, I.; Dahl, S.G. Structure and localisation of drug bindingsites on neurotransmitter transporters. J. Mol. Model., 2009, 15, 1155-1164.
66. Lin, Z.; Wang, W.; Kopajtic, T.; Revay, R.S.; Uhl, G.R. Dopaminetransporter: transmembrane phenylalanine mutations can selectivelyinfluence dopamine uptake and cocaine analog recognition. Mol. Pharmacol., 1999, 56, 434-447. (Pubitemid 29347622)
67. Larsen, M.B.; Elfving, B.; Wiborg, O. The chicken serotonin transporterdiscriminates between serotonin-selective reuptake inhibitors. A speciesscanningmutagenesis study. J. Biol. Chem., 2004, 279, 42147-42156. (Pubitemid 39313664)
68. Lee, S.H.; Chang, M.Y.; Lee, K.H.; Park, B.S.; Lee, Y.S.; Chin, H.R.Importance of valine at position 152 for the substrate transport and 2betacarbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopaminetransporter. Mol. Pharmacol., 2000, 57, 883-889. (Pubitemid 30253370)
69. Mortensen, O.V.; Kristensen, A.S.; Wiborg, O. Species-scanningmutagenesis of the serotonin transporter reveals residues essential inselective, high-affinity recognition of antidepressants. J. Neurochem., 2001, 79, 237-247. (Pubitemid 32988939)
70. Roubert, C.; Cox, P.J.; Bruss, M.; Hamon, M.; Bonisch, H.; Giros, B.Determination of residues in the norepinephrine transporter that are criticalfor tricyclic antidepressant affinity. J. Biol. Chem., 2001, 276, 8254-8260.
71. Lin, Z.; Wang, W.; Uhl, G.R. Dopamine transporter tryptophan mutantshighlight candidate dopamine- and cocaine-selective domains. Mol. Pharmacol., 2000, 58, 1581-1592.
72. Korkhov, V.M.; Holy, M.; Freissmuth, M.; Sitte, H.H. The conservedglutamate (Glu136) in transmembrane domain 2 of the serotonin transporteris required for the conformational switch in the transport cycle. J. Biol. Chem., 2006, 281, 13439-13448. (Pubitemid 43855256)
73. Itokawa, M.; Lin, Z.; Cai, N.S.; Wu, C.; Kitayama, S.; Wang, J.B.; Uhl, G.R.Dopamine transporter transmembrane domain polar mutants: DeltaG andDeltaDeltaG values implicate regions important for transporter functions.Mol. Pharmacol., 2000, 57, 1093-1103. (Pubitemid 30354381)
74. Zomot, E.; Bendahan, A.; Quick, M.; Zhao, Y.; Javitch, J.A.; Kanner, B.I.Mechanism of chloride interaction with neurotransmitter:sodium symporters.Nature, 2007, 449, 726-730. (Pubitemid 47552085)
75. Forrest, L.R.; Tavoulari, S.; Zhang, Y.W.; Rudnick, G.; Honig, B.Identification of a chloride ion binding site in Na+/Cl - dependenttransporters. Proc. Natl. Acad. Sci. USA, 2007, 104, 12761-12766. (Pubitemid 47255228)
76. Field, J.R.; Henry, L.K.; Blakely, R.D. Transmembrane domain 6 of thehuman serotonin transporter contributes to an aqueously accessible bindingpocket for serotonin and the psychostimulant 3, 4- methylenedioxymethamphetamine. J. Biol. Chem., 2010, 285, 11270-11280.
77. Zhang, Y.W.; Rudnick, G. The cytoplasmic substrate permeation pathway ofserotonin transporter. J. Biol. Chem., 2006, 281, 36213-36220. (Pubitemid 46043244)
78. + antiporter and insights into mechanism of action andregulation by pH. Nature, 2005, 435, 1197-1202. (Pubitemid 40943079)